PNC-27: Reference Overview and Reconstitution Notes

PNC-27 is a man-made peptide (a short chain of protein building blocks) that joins a piece of a natural cell-control protein to a segment that helps it stick to cell walls. It is studied in cancer cell biology research. It is research-only and not approved by the FDA.

PNC-27

What it is

PNC-27 is a man-made, mixed-design peptide. Think of a peptide as a very short protein, like a tiny string of beads. PNC-27 is roughly 27 to 32 amino acids (the individual "beads") long.

It is built from two joined parts. The first part comes from a section of the p53 protein (a natural protein inside cells that helps keep cell growth under control). This particular section is known for latching onto another protein called HDM-2. The second part is a short "leader" segment that helps the whole peptide attach to and enter cell membranes (the outer walls of cells).

It belongs to a family of lab-designed, p53-based research peptides built to interact with cell walls.

Research context and categorization

PNC-27 falls under oncology and cancer-cell-biology research (the scientific study of cancer cells in the lab). It is not grouped with wellness, metabolism, or anti-aging research.

Proposed Mechanism of Action

Researchers propose that PNC-27 works by attaching to HDM-2 protein that has moved to the outer membrane (wall) of certain cancer cells. Think of it like a key that only fits a lock found on the outside of specific cell walls. In lab models, this attachment appears to punch holes in the cell wall and cause the cell to break apart. This breaking apart is called cell lysis (pronounced "lie-sis").

Studies have found that this wall-surface form of HDM-2 appears on various types of cancer cell lines (lab-grown cancer cells) but not on normal, healthy cell lines. Because of that difference, PNC-27 has been studied for its ability to act selectively on cancer cells in lab dishes. Researchers have also looked at it in leukemia (blood cancer) and cervical cancer cell models.

Preclinical Research Status

These findings are strictly investigational, meaning they are early-stage lab results only. PNC-27 has not gone through human clinical trials (studies conducted in people). None of the effects seen in lab reports are confirmed or approved outcomes. All of this is preclinical research (done in labs, not in people), not established fact.

Key point: PNC-27 is an investigational compound with zero human clinical trial data. Its safety and how well it works in humans are completely unknown.

Status

• Regulatory status: Research-only, not FDA-approved. There is no approved use in humans and no established human safety data.
• Sport status: PNC-27 is not listed by name on the WADA Prohibited List (the global list of banned substances for competitive athletes). However, as a non-approved man-made peptide, it would generally fall under the WADA S0 (Non-Approved Substances) catch-all category. This category covers substances not addressed elsewhere that have not been approved for human use. Anyone subject to drug testing should check the current official WADA Prohibited List to confirm the status.

Reconstitution notes (general)

PNC-27 ships as a lyophilized (freeze-dried) powder. Freeze-drying removes water to make the compound stable for shipping and storage, similar in concept to instant coffee granules. Before lab use, it must be reconstituted (mixed back into liquid form).

The resulting concentration is found by dividing the milligrams of peptide in the vial by the milliliters of liquid added. For example, dividing the vial contents by the volume of liquid gives the milligrams-per-milliliter figure. A reconstitution calculator is available at the peptide calculator.

Dilution and handling notes (compound-specific)

PNC-27 vials commonly hold 2 mg to 30 mg of powder and are mixed with bacteriostatic water (a sterile water with a small amount of preservative that slows bacterial growth). A common example is adding about 3.0 mL of bacteriostatic water to a 30 mg vial, which gives a concentration of roughly 10 mg/mL. The exact volume chosen depends on what concentration a specific lab protocol calls for.

Handling and Dissolving Challenges

PNC-27 is a longer peptide that contains both the p53-derived section and the cell-wall-attaching leader segment. Part of its structure repels water (this property is called hydrophobic, meaning "water-fearing"). Because of this, it can be slower and trickier to dissolve than a short, fully water-friendly peptide. It foams easily and can clump together (a process called aggregation) if handled too roughly.

Step-by-Step Reconstitution Process

1. Add the water slowly along the inside wall of the vial, not directly onto the powder. (Think of pouring a carbonated drink down the side of a glass to limit the foam.)
2. Swirl or gently roll the vial and let it rest without vigorous shaking or vortexing (high-speed spinning). This limits foaming and helps protect the peptide from breaking down (a process called denaturation).
3. Check the solution for clarity. If it stays hazy, cloudy, or shows gel-like threads that do not clear up with continued gentle swirling and a short rest, that points to incomplete solubilization (the peptide has not fully dissolved). Material that has not fully dissolved should not be treated as a usable stock.
4. Avoid freeze-thaw cycles (repeatedly freezing and then thawing the vial). This can break down the peptide over time.

Handling and storage

• Store the freeze-dried powder cold and dry, away from light.
• Once reconstituted (mixed into liquid), keep it refrigerated at 2 to 8°C (about 36 to 46°F), away from light. Wipe the rubber stopper with alcohol before drawing from the vial.
• Write the mix date and concentration on the vial label.
• A reconstituted, refrigerated solution is generally treated as usable for up to about a 4-week window as an outer limit.
• Throw out the vial if the liquid becomes cloudy or discolored, or if you see floating particles.

Related reading

• Prostamax
• PTD-DBM
• Selank
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is PNC-27 and how does it work in lab research?

PNC-27 is a synthetic peptide combining a p53 protein segment with a membrane-anchoring leader. Researchers propose it binds HDM-2 on cancer cell membranes, causing cell lysis in lab models. All findings are preclinical only.

Is PNC-27 FDA-approved or legal for human use?

No. PNC-27 is strictly research-only, not FDA-approved, and has zero human clinical trial data. Its safety and efficacy in humans are entirely unknown. It is not approved for any human or veterinary application.

How is lyophilized PNC-27 reconstituted for laboratory use?

PNC-27 lyophilized powder is reconstituted by slowly introducing bacteriostatic water into the vial using a reconstitution pen, then gently swirling until dissolved. The resulting solution is for in-vitro lab use only.

What the research community gets wrong about PNC-27

• It is not a treatment. Everything published on PNC-27 comes from cell dishes and lab models. There are no human clinical trials, so calling it a therapy or a drug reads far past what the papers actually show.
• The action people describe happens at the cell wall, not inside. A common mix-up is to picture the p53 part switching on the normal p53 pathway inside a cell. The proposed lab mechanism is different: the peptide binds HDM-2 sitting on the outer membrane and forms pores there.
• The selectivity seen in dishes is tied to one thing. In lab models the peptide affected cancer cell lines but not the normal lines tested, and that difference tracked with membrane HDM-2 being present. It is not a blanket rule that the peptide can tell any two cell types apart.
• It does not dissolve like a simple, water-friendly peptide. Part of the sequence is hydrophobic (water-fearing), so at the bench it can go into solution slowly, foam easily, and clump. Treating it like an easy short peptide leads to hazy stocks.
• Harder shaking does not speed it up. Vortexing or vigorous shaking adds air and shear that push the peptide to foam and aggregate. Gentle swirling and a short rest do more than force.
• PNC-27 and PNC-28 are not the same reagent. They are related p53-based research peptides and are easy to confuse in notes and orders, but they are distinct sequences with their own literature.

From our bench: When you reconstitute a PNC-27 vial, tell us what you actually saw at the glass. How long did the powder take to clear after gentle swirling, did the solution foam or throw haze at the concentration you mixed, and did any gel-like threads show up before it settled? Post your real numbers and observations (vial size, water volume, temperature, and time to clarity) so other researchers can compare handling notes instead of guessing.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. Sarafraz-Yazdi E, et al. PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2... Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis. Biomedicines, 2022. (PMID 35625682)
5. Thadi A, et al. Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells. Anticancer Research, 2020. (PMID 32878773)
6. Sarafraz-Yazdi E, Bowne WB, Adler V, et al. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. PNAS, 2010;107(5):1918-23. (PMID 20080680)